Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01355289
What this trial is testing

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

Who this might be right for
Thrombocytopenia
Eisai Inc. 65
Large-scale testing (Phase 3)UnknownNCT06383468
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 420
Early research (Phase 1)Study completedNCT01590446
What this trial is testing

Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

Who this might be right for
Achondroplasia
BioMarin Pharmaceutical 74
Testing effectiveness (Phase 2)UnknownNCT01680003
What this trial is testing

Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Nova Laboratories Sdn Bhd 50
Large-scale testing (Phase 3)Ended earlyNCT06514742
What this trial is testing

Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 101
Large-scale testing (Phase 3)Active Not RecruitingNCT04908189
What this trial is testing

Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 729
Testing effectiveness (Phase 2)WithdrawnNCT04584697
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

Who this might be right for
Covid19
Sorrento Therapeutics, Inc.
Post-approval studies (Phase 4)UnknownNCT01116310
What this trial is testing

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause

Who this might be right for
Postmenopausal Women With Moderate Vasomotor Symptoms
Laboratorios Casen-Fleet S.L.U. 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513546
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients

Who this might be right for
Amyotrophic Lateral SclerosisALS
PLL TX AUSTRALIA PTY LTD 153
Early research (Phase 1)Study completedNCT01831427
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 74
Large-scale testing (Phase 3)Study completedNCT01583374
What this trial is testing

Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondyloarthritis
Amgen 490
Large-scale testing (Phase 3)Looking for participantsNCT06905210
What this trial is testing

Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Who this might be right for
Acne VulgarisAcne Vulgaris on the Face
Eurofarma Laboratorios S.A. 531
Large-scale testing (Phase 3)Looking for participantsNCT07190196
What this trial is testing

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

Who this might be right for
Immunoglobulin G4 Related Disease
Sanofi 124
Testing effectiveness (Phase 2)UnknownNCT04413942
What this trial is testing

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 99
Large-scale testing (Phase 3)Looking for participantsNCT05755386
What this trial is testing

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Who this might be right for
IC-MPGN
Novartis Pharmaceuticals 106
Testing effectiveness (Phase 2)Study completedNCT00885170
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 246
Early research (Phase 1)Looking for participantsNCT07790770
What this trial is testing

A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in Healthy Participants

Who this might be right for
Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria
Dermavon Holdings Limited 72
Early research (Phase 1)UnknownNCT06482541
What this trial is testing

Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Levit Dermatology 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687890
What this trial is testing

Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseIgA Nephropathy
Biocity Biopharmaceutics Co., Ltd. 255
Testing effectiveness (Phase 2)Study completedNCT00279760
What this trial is testing

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 210
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation